Aethlon Medical Statistics

Total Valuation

Aethlon Medical has a market cap or net worth of $2.82 million. The enterprise value is -$2.55 million.

Market Cap	2.82M
Enterprise Value	-2.55M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Aethlon Medical has 761,318 shares outstanding. The number of shares has increased by 191.00% in one year.

Current Share Class	761,318
Shares Outstanding	761,318
Shares Change (YoY)	+191.00%
Shares Change (QoQ)	+91.44%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	11.91%
Float	756,925

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.09.

Current Ratio	4.45
Quick Ratio	4.32
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-701.20

Financial Efficiency

Return on equity (ROE) is -191.39% and return on invested capital (ROIC) is -67.61%.

Return on Equity (ROE)	-191.39%
Return on Assets (ROA)	-54.79%
Return on Invested Capital (ROIC)	-67.61%
Return on Capital Employed (ROCE)	-119.78%
Revenue Per Employee	n/a
Profits Per Employee	-$1.25M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.91% in the last 52 weeks. The beta is 1.64, so Aethlon Medical's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	-87.91%
50-Day Moving Average	5.38
200-Day Moving Average	18.10
Relative Strength Index (RSI)	40.83
Average Volume (20 Days)	100,773

Short Selling Information

The latest short interest is 42,005, so 5.52% of the outstanding shares have been sold short.

Short Interest	42,005
Short Previous Month	36,998
Short % of Shares Out	5.52%
Short % of Float	5.55%
Short Ratio (days to cover)	0.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.09M
Pretax Income	-11.26M
Net Income	-11.26M
EBITDA	-6.76M
EBIT	-7.09M
Earnings Per Share (EPS)	-$46.60

Full Income Statement

Balance Sheet

The company has $5.85 million in cash and $542,411 in debt, giving a net cash position of $5.31 million or $6.98 per share.

Cash & Cash Equivalents	5.85M
Total Debt	542,411
Net Cash	5.31M
Net Cash Per Share	$6.98
Equity (Book Value)	5.75M
Book Value Per Share	7.55
Working Capital	4.85M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.06M
Capital Expenditures	n/a
Free Cash Flow	-7.06M
FCF Per Share	-$9.27

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Aethlon Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-191.00%
Shareholder Yield	-191.00%
Earnings Yield	-407.39%
FCF Yield	-255.36%

Analyst Forecast

The average price target for Aethlon Medical is $287.50, which is 7,670.27% higher than the current price. The consensus rating is "Buy".

Price Target	$287.50
Price Target Difference	7,670.27%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-47.67%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 20, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Oct 20, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2